Clinical Trial Update: Docosahexenoic Acid (DHA) Supplementation and Cardiovascular Disease in Men With High Triglycerides [NA]

View source ↗

Summary

A completed clinical trial evaluated docosahexaenoic acid (DHA) supplementation for cardiovascular outcomes in men with high triglycerides.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertriglyceridemia

Drugs mentioned

• Docosahexaenoic acid (DHA) (docosahexaenoic acid)

Snippet

Sponsor: USDA, Western Human Nutrition Research Center | Conditions: Hypertriglyceridemia | NA | Status: COMPLETED